Beruflich Dokumente
Kultur Dokumente
OF INDAPAMIDE
Presented by:
GUIDED BY :
Hipparge Nurpasha
Dr. Mrs. Mayura Kale
M Pharm (PChem.) II Sem
Assistant Professor
Department of Pharm. Chemistry
GOVERNMENT COLLEGE OF PHARMACY
1
Internal Examiner
External Examiner
CONTENTS
Introduction
Literature survey
Plan of work
Feasibility
Problem
Expected
Outcomes
References
INDAPAMIDE:
ofhypertension,
as
well
as
decompensatedheart failure.
Combination
Chemical data
Formula
C16H16ClN3O3S
Molecular mass
365.835 g/mol
IUPAC Name
4-chloro-N-(2-methyl-2,3-dihydro1H-indol-1-yl)-3sulfamoylbenzamide
Description
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Sub Class
Benzenesulfonamides
Direct Parent
Benzenesulfonamides
Categories
Antihypertensive Agents
Diuretics
Sodium Chloride Symporter
Inhibitors
5
Pharmacology
Indication
Mechanism of action
Absorption
SYNTHESIS OF INDAPAMIDE
G-QSAR:
JUSTIFICATION
Novelty:
Synthesis
Various
biological activity
Usefulness:
Therapeutic
11
PLAN OF WORK
Literature survey
Synthesis of derivatives
12
LITERATURE SURVEY
Dong H., Quan B. et.al. synthesized 5-methyl-3-substituted1,2,4-triazolo[3,4-b] benzothiazoles (Journal of molecular
structure, 2002; 41-47)
Shivaraj H, Gazi S, Patil S, Surwas S. Synthesis and biological
evaluation of some benzothiazole derivatives. Asian J
Research Chem. 2010; 3(2):421-427.
P S Yadav et al Benzothiazole: Different Methods of
Synthesis and Diverse Biological ActivitiesBharathi
College of Pharmacy, Bharathinagara, Mandya,
Karnataka- 571422, India.
13
CONT..
Kuberkar S.V.,Pingle M .S et al.; A Convenient synthesis of
3-cyano-4-imino-2-methylthiyo-4H-pyrimido benzothiazole
and its reaction with selected nucleiophiles; ARKIVOC 2006
(X) 190-198.
H
Anhy.
H3C
NH2
S
N
SCH3
K2CO3
SCH3
H3C
H3C
SCH3
SCH3
O
N
CN
O
14
1)High
risk alert
2)Medium
3)Low
risk alert
risk alert
)
Mutagenic
Medium risk
)
Tumerogenic)
Irritant-
Medium risk
Medium risk
15
FEASIBILITY
Process
Sources Available
Synthesis of compounds
IR spectometer
Weighing of product
Electonic balance
Drying of product
Freezer
Pharmacological screening
Filtration
17
SOLUTION
Recrystalization
Solvent combination
EXPECTED OUTCOME
19
REFERENCES
CONT
Vogels
G-QSAR
of Novel 2-{[2-(1H-imidazol-1-yl)ethyl]sulfanyl}1Hbenzimidazole
Derivatives
MAYURA
KALE*,
GAJANAN SONWANE and RAJESH NAWALE
Department ofPharmaceutical Chemistry, Government
College of Pharmacy,Osmanpura, Aurangabad, Maharashtra,
India.
21
CONT..
Morrision,R.T.,Boyd,R.N.,Organic
Chemistry, Newyork-Pearson Education,VI
Edition,2003,504-505.
23